Assessing the Role of Bempedoic Acid in Lipid-Lowering Therapy

Am J Cardiol. 2024 Apr 1:216:93-94. doi: 10.1016/j.amjcard.2024.02.002. Epub 2024 Feb 17.

Authors

David Fernandez-Vazquez¹, Sarah Weideman², Subhash Banerjee²

Affiliations

¹ Baylor Scott & White Research Institute, Cardiology, Dallas, Texas. Electronic address: davisfv91@gmail.com.
² Baylor Scott & White Research Institute, Cardiology, Dallas, Texas.

PMID: 38369175
DOI: 10.1016/j.amjcard.2024.02.002

No abstract available

Publication types

Editorial

MeSH terms

Anticholesteremic Agents*
Dicarboxylic Acids / therapeutic use
Fatty Acids
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Hypercholesterolemia*

Substances

8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
Fatty Acids
Dicarboxylic Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Anticholesteremic Agents